Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010

Overview

Journal Environ Health Perspect

Date 2015 Jun 10

PMID 26058082

Citations 55

Authors

Naila Khalil

Aimin Chen

Miryoung Lee

Stefan A Czerwinski

James R Ebert

Jamie C DeWitt

Kurunthachalam Kannan

Affiliations

Soon will be listed here.

Abstract

Background: Perfluoroalkyl substances (PFASs), including perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), perfluorohexane sulfonic acid (PFHxS), and perfluorononanoic acid (PFNA), are detectable in the serum of 95% of the U.S.

Objective: Considering the role of PFASs as endocrine disruptors, we examined their relationships with bone health.

Methods: The association between serum PFAS concentration and bone mineral density at total femur (TFBMD), femoral neck (FNBMD), lumbar spine (LSBMD), and physician-diagnosed osteoporosis was assessed in 1,914 participants using data from the National Health and Nutritional Examination Survey 2009-2010.

Results: The mean age of the participants was 43 years. Men had higher serum PFAS concentrations than women (p < 0.001) except for PFNA. In both sexes, serum PFOS concentrations were inversely associated with FNBMD (p < 0.05). In women, significant negative associations were observed for natural log (ln)-transformed PFOS exposure with TFBMD and FNBMD, and for ln-transformed PFOA exposure with TFBMD (p < 0.05). In postmenopausal women, serum PFOS was negatively associated with TFBMD and FNBMD, and PFNA was negatively associated with TFBMD, FNBMD, and LSBMD (all p < 0.05). With one log unit increase in serum PFOA, PFHxS, and PFNA, osteoporosis prevalence in women increased as follows: [adjusted odds ratios (aORs)] 1.84 (95% CI: 1.17, 2.905), 1.64 (95% CI: 1.14, 2.38), and 1.45 (95% CI: 1.02, 2.05), respectively. In women, the prevalence of osteoporosis was significantly higher in the highest versus the lowest quartiles of PFOA, PFHxS, and PFNA, with aORs of 2.59 (95% CI: 1.01, 6.67), 13.20 (95% CI: 2.72, 64.15), and 3.23 (95% CI: 1.44, 7.21), respectively, based on 77 cases in the study sample.

Conclusion: In a representative sample of the U.S. adult population, serum PFAS concentrations were associated with lower bone mineral density, which varied according to the specific PFAS and bone site assessed. Most associations were limited to women. Osteoporosis in women was also associated with PFAS exposure, based on a small number of cases.

Citation: Khalil N, Chen A, Lee M, Czerwinski SA, Ebert JR, DeWitt JC, Kannan K. 2016. Association of perfluoroalkyl substances, bone mineral density, and osteoporosis in the U.S. population in NHANES 2009-2010. Environ Health Perspect 124:81-87; http://dx.doi.org/10.1289/ehp.1307909.

Citing Articles

Associations of PFAS concentrations during pregnancy and midlife with bone health in midlife: Cross-sectional and prospective findings from Project Viva.

Lin P, Cardenas A, Rokoff L, Rifas-Shiman S, Zhang M, Botelho J Environ Int. 2024; 194:109177.

PMID: 39667063 PMC: 11683763. DOI: 10.1016/j.envint.2024.109177.

Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018.

Chen R, Gong K, Chen W, Chen Z, Hua X, Tan J Osteoporos Int. 2024; 36(2):283-297.

PMID: 39611944 DOI: 10.1007/s00198-024-07324-w.

Sex-specific association of per- and polyfluoroalkyl substances (PFAS) exposure with vitamin D concentrations in older adults in the USA: an observational study.

Zhao H, Ren Y, Ni J, Fang L, Zhang T, Wang M Environ Health. 2024; 23(1):100.

PMID: 39551762 PMC: 11571557. DOI: 10.1186/s12940-024-01140-9.

Mid-Childhood Plasma Concentrations of Per- and Polyfluoroalkyl Substances, Modifiable Lifestyle Factors, and Bone Mineral Density Through Late Adolescence.

Rokoff L, Rifas-Shiman S, Aris I, Lin P, Rosen C, Calafat A Environ Sci Technol. 2024; 58(45):19970-19980.

PMID: 39485370 PMC: 11562948. DOI: 10.1021/acs.est.4c08480.

Association of dietary carbohydrate intake with bone mineral density, osteoporosis and fractures among adults without diabetes: Evidence from National Health and Nutrition Examination Survey.

Chen R, Gong K, Chen W, Chen Z, Zhang L, Tang Y Heliyon. 2024; 10(15):e35566.

PMID: 39170357 PMC: 11336747. DOI: 10.1016/j.heliyon.2024.e35566.

References

Tucker J, Welk G, Beyler N . Physical activity in U.S.: adults compliance with the Physical Activity Guidelines for Americans. Am J Prev Med. 2011; 40(4):454-61. DOI: 10.1016/j.amepre.2010.12.016. View

Long M, Ghisari M, Bonefeld-Jorgensen E . Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor. Environ Sci Pollut Res Int. 2013; 20(11):8045-56. DOI: 10.1007/s11356-013-1628-7. View

Pollack A, Mumford S, Wactawski-Wende J, Yeung E, Mendola P, Mattison D . Bone mineral density and blood metals in premenopausal women. Environ Res. 2012; 120:76-81. PMC: 3534953. DOI: 10.1016/j.envres.2012.06.001. View

Yu W, Liu W, Jin Y, Liu X, Wang F, Liu L . Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system. Environ Sci Technol. 2009; 43(21):8416-22. DOI: 10.1021/es901602d. View

Domingo J . Health risks of dietary exposure to perfluorinated compounds. Environ Int. 2011; 40:187-195. DOI: 10.1016/j.envint.2011.08.001. View

Paganini-Hill A, Atchison K, Gornbein J, Nattiv A, Service S, White S . Menstrual and reproductive factors and fracture risk: the Leisure World Cohort Study. J Womens Health (Larchmt). 2005; 14(9):808-19. DOI: 10.1089/jwh.2005.14.808. View

Lind P, Oberg D, Larsson S, Kyle C, Orberg J, Rhind S . Pregnant ewes exposed to multiple endocrine disrupting pollutants through sewage sludge-fertilized pasture show an anti-estrogenic effect in their trabecular bone. Sci Total Environ. 2010; 408(11):2340-6. DOI: 10.1016/j.scitotenv.2010.01.059. View

Lin L, Wen L, Su T, Chen P, Lin C . Negative association between serum perfluorooctane sulfate concentration and bone mineral density in US premenopausal women: NHANES, 2005-2008. J Clin Endocrinol Metab. 2014; 99(6):2173-80. DOI: 10.1210/jc.2013-3409. View

Tuppurainen M, Kroger H, Saarikoski S, Honkanen R, Alhava E . The effect of gynecological risk factors on lumbar and femoral bone mineral density in peri- and postmenopausal women. Maturitas. 1995; 21(2):137-45. DOI: 10.1016/0378-5122(94)00878-b. View

10.

Cauley J, Fullman R, Stone K, Zmuda J, Bauer D, Barrett-Connor E . Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int. 2005; 16(12):1525-37. DOI: 10.1007/s00198-005-1866-8. View

11.

Cummings S, Kelsey J, Nevitt M, ODowd K . Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985; 7:178-208. DOI: 10.1093/oxfordjournals.epirev.a036281. View

12.

Hukkanen J, Jacob 3rd P, Benowitz N . Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005; 57(1):79-115. DOI: 10.1124/pr.57.1.3. View

13.

Lopez-Espinosa M, Fletcher T, Armstrong B, Genser B, Dhatariya K, Mondal D . Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ Sci Technol. 2011; 45(19):8160-6. DOI: 10.1021/es1038694. View

14.

Knox S, Jackson T, Javins B, Frisbee S, Shankar A, Ducatman A . Implications of early menopause in women exposed to perfluorocarbons. J Clin Endocrinol Metab. 2011; 96(6):1747-53. PMC: 3206400. DOI: 10.1210/jc.2010-2401. View

15.

Kato K, Wong L, Jia L, Kuklenyik Z, Calafat A . Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. Environ Sci Technol. 2011; 45(19):8037-45. DOI: 10.1021/es1043613. View

16.

White S, Fenton S, Hines E . Endocrine disrupting properties of perfluorooctanoic acid. J Steroid Biochem Mol Biol. 2011; 127(1-2):16-26. PMC: 3335904. DOI: 10.1016/j.jsbmb.2011.03.011. View

17.

Bogdanska J, Borg D, Sundstrom M, Bergstrom U, Halldin K, Abedi-Valugerdi M . Tissue distribution of ³⁵S-labelled perfluorooctane sulfonate in adult mice after oral exposure to a low environmentally relevant dose or a high experimental dose. Toxicology. 2011; 284(1-3):54-62. DOI: 10.1016/j.tox.2011.03.014. View

18.

Cui L, Zhou Q, Liao C, Fu J, Jiang G . Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis. Arch Environ Contam Toxicol. 2008; 56(2):338-49. DOI: 10.1007/s00244-008-9194-6. View

19.

Hannan M, Felson D, Dawson-Hughes B, Tucker K, Cupples L, Wilson P . Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res. 2000; 15(4):710-20. DOI: 10.1359/jbmr.2000.15.4.710. View

20.

Peeters G, Tett S, Dobson A, Mishra G . Validity of self-reported osteoporosis in mid-age and older women. Osteoporos Int. 2012; 24(3):917-27. DOI: 10.1007/s00198-012-2033-7. View